Mental state: clinically important response, as defined by individual studies * · patients with schizophrenia
1 finding from 1 review
Functioning: clinically important change in general functioning, as defined by individual studies · patients with schizophrenia
1 finding from 1 review
Global state: clinically important change in global state · patients with schizophrenia
1 finding from 1 review
Mental state: clinically important response, as defined by individual studies * · patients with schizophrenia
1 finding from 1 review
NSI‐ change in level ‐ Gradual introduction · preventing percutaneous exposure injuries caused by needles in healthcare personnel
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
NSI‐ Change in slope ‐ Gradual introduction · preventing percutaneous exposure injuries caused by needles in healthcare personnel
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
Engagement with services: clinically important change in engagement with services, as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment adherence: clinically important change in treatment adherence, as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Understanding: clinically important change in understanding the nature of illness and its outcome, as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life: clinically important change in quality of life · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mental state: clinically important change in mental state · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction communication of diagnosis: clinically important change (patient or carer's), as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effect: clinically important adverse effect of intervention ‐ as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Individual antimicrobial resistance · Women who had normal vaginal births
1 finding from 1 review
Proportion of participants with anomalous head position preoperatively with residual head tilt postoperatively · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants with anomalous head position preoperatively with residual head tilt postoperatively · people with unilateral superior oblique palsy
It is very uncertain whether inferior oblique disinsertion changes proportion of participants with anomalous head position… compared with anterior transposition (very low certainty).
1 finding from 1 review
Overall signs of postoperative residual paralysis · Adult patients, ASA I‐IV, who received non‐depolarizing NMBAs
Sugammadex (any dose) probably leads to lower overall signs of postoperative residual paralysis compared with neostigmine (any dose) (moderate certainty).
1 finding from 1 review
Risk of adverse events and serious adverse eventsb, bradycardia, PONV, and signs of residual neuromuscular blockade · Adult patients, ASA I‐IV, who received non‐depolarizing NMBAs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Risk of adverse events and serious adverse eventsb, bradycardia, PONV, and signs of residual neuromuscular blockade · Adult patients, ASA I‐IV, who received non‐depolarizing NMBAs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life: clinically important change in quality of life · patients with schizophrenia
1 finding from 1 review